SCHEMBL19998856

SCHEMBL19998856

Cc1cc(C)cc(-c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccc(N(c6ccc(-c7ccccc7)cc6)c6ccc(-c7cc8ccccc8c8ccccc78)cc6)cc5)cc4)cc3)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MPI P34949 1/20 0.41
▸ GPR84 Q9NQS5 4/20 0.40
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ PSMB5 P28074 3/20 0.37
▸ USP2 O75604 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CTNNB1 P35222 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19998838 1.00 CYP11B1 (0.41) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL19998848 1.00 CYP11B1 (0.41) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL19998860 1.00 CYP11B1 (0.41) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL19998837 0.94 CYP11B1 (0.41) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL23822426 0.90 CYP11B1 (0.46) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL24221840 0.89 MEN1 (0.49) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL23448070 0.89 MEN1 (0.49) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL22669958 0.89 MEN1 (0.49) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL21796044 0.89 MEN1 (0.49) CYP11B1MEN1KMT2AALDH1A1MAPT
SCHEMBL23448013 0.89 MEN1 (0.49) CYP11B1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC18A1, SLC1A2, SLC43A1 CYP11B1 1384/4885MEN1 4059/4885KMT2A 1493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback